Therapeutic Potential in Targeting the FcRn Receptor: Clinical Overview and Future Opportunities

Time: 3:00 pm
day: Day Two


  • FcRn is a promising therapeutic target because it has a vital role in prolonging the half-life of IgG blood levels
  • FcRn inhibitors are in clinical development for numerous autoantibodymediated diseases
  • FcRn effects may vary with physiological location and additional effects are still being discovered